GPX4 and cancer: Given the concern that GPX4 inhibitors may have unacceptable toxicity in humans (57–59), discovery of combinatorial approaches such as these to selectively sensitize cancer cell populations may be critical to enable the realization of a clinically effective and safe ferroptosis-based drug treatment for cancer.